T3 Companies, LLC

Position in NRXS — Neuraxis, INC

CIK 2052441 NEW YORK, NY

Position in NRXS

as of Mar 31, 2026 · filed May 7, 2026 Compact

Position Value

$221,415

New position

Shares Held

29,921

first reported quarter

Ownership

0.238%

of shares outstanding

% of Portfolio

0.39%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

T3 Companies, LLC holds $2,660,789 across 5 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	ABVX	Abivax S.A.	7,815	$1,041,426
2	IFRX	InflaRx N.V.	331,014	$741,471
3	YARW	Yarrow Bioscience, Inc.	18,900	$615,195
4	CLDX	Celldex Therapeutics, Inc.	6,000	$223,260
5	SANA	Sana Biotechnology, Inc.	11,300	$39,437

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$221,415	29,921	—	Shares	Sole	2026-05-07
No filing history on record for this holder in this stock.